• Noctrix Health: Wearable Therapeutics For RLS

  • May 28 2024
  • Duración: 39 m
  • Podcast

Noctrix Health: Wearable Therapeutics For RLS  Por  arte de portada

Noctrix Health: Wearable Therapeutics For RLS

  • Resumen

  • Host Mike Moore sits down with Shri Rhagunathan, President & CEO of Noctrix Health. Noctrix has the developed the only FDA approved device to Restless Legs Syndrome (RLS). This disease affects 1 in 10 Americans, and is the 2nd most common sleep disorder in the U.S. A limited number of pharmaceutical options currently exist to treat this disease state, all of which have a number of associated negative side effects. Their Nidra devices is a paradigm shifting breakthrough in a heavily under treated patient population.

    Resources & Links
    LinkedIn: Mike Moore
    LinkedIn: The Bleeding Edge of Digital Health

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Noctrix Health: Wearable Therapeutics For RLS

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.